Several other studies approved the significant elevation of IL-6, procalcitonin (PCT) and CRP in severe or critical COVID-19 patients 3-5; moreover, a retrospective, multicentre cohort study also observed a notable elevation of serum IL-6 level in deceased COVID-19 patients compared with that of the survivors 6. This evidence concerns the gene CRP and COVID-19.